Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	G protein-coupled receptor activity	OR2B2 TRHR OR2T27 OR5AU1 OR2T35 OR4Q3 LGR4 TAAR2 OR2T1 NLRP6 OR1F1 OR1L8 ADORA1 OR5J2 OR4S1 OR6B3 C3AR1 OR6B2	2.01e-06	884	112	18	GO:0004930
GeneOntologyMolecularFunction	olfactory receptor activity	OR2B2 OR2T27 OR5AU1 OR2T35 OR4Q3 OR2T1 OR1F1 OR1L8 OR5J2 OR4S1 OR6B3 OR6B2	5.53e-06	431	112	12	GO:0004984
GeneOntologyMolecularFunction	ubiquitin-like ligase-substrate adaptor activity	PRAMEF9 PRAMEF15 PRAMEF4 FBXL2 PRAMEF27 PRAMEF11	6.74e-06	82	112	6	GO:1990756
GeneOntologyMolecularFunction	enzyme-substrate adaptor activity	PRAMEF9 PRAMEF15 PRAMEF4 FBXL2 PRAMEF27 PRAMEF11	1.58e-05	95	112	6	GO:0140767
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	OR2B2 TRHR OR2T27 OR5AU1 OR2T35 OR4Q3 LGR4 TAAR2 OR2T1 CR2 NLRP6 OR1F1 OR1L8 ADORA1 OR5J2 OR4S1 OR6B3 C3AR1 LTBP1 OR6B2	5.84e-05	1353	112	20	GO:0004888
GeneOntologyMolecularFunction	purine nucleoside binding	OARD1 ADORA1	1.86e-04	4	112	2	GO:0001883
GeneOntologyMolecularFunction	nuclear retinoic acid receptor binding	PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	2.57e-04	55	112	4	GO:0042974
GeneOntologyBiologicalProcess	detection of chemical stimulus involved in sensory perception of smell	OR2B2 OR2T27 OR5AU1 OR2T35 OR4Q3 OR2T1 OR1F1 OR1L8 OR5J2 OR4S1 OR6B3 OR6B2	4.08e-06	432	112	12	GO:0050911
GeneOntologyBiologicalProcess	detection of chemical stimulus	OR2B2 OR2T27 OR5AU1 OR2T35 OR4Q3 OR2T1 NOD2 OR1F1 OR1L8 OR5J2 OR4S1 OR6B3 OR6B2	5.43e-06	524	112	13	GO:0009593
GeneOntologyBiologicalProcess	sensory perception of smell	OR2B2 OR2T27 OR5AU1 OR2T35 OR4Q3 OR2T1 OR1F1 OR1L8 OR5J2 OR4S1 OR6B3 OR6B2	8.61e-06	465	112	12	GO:0007608
GeneOntologyBiologicalProcess	detection of chemical stimulus involved in sensory perception	OR2B2 OR2T27 OR5AU1 OR2T35 OR4Q3 OR2T1 OR1F1 OR1L8 OR5J2 OR4S1 OR6B3 OR6B2	1.31e-05	485	112	12	GO:0050907
GeneOntologyBiologicalProcess	detection of stimulus involved in sensory perception	OR2B2 OR2T27 OR5AU1 OR2T35 OR4Q3 OR2T1 OR1F1 OR1L8 ADORA1 OR5J2 OR4S1 OR6B3 OR6B2	1.66e-05	582	112	13	GO:0050906
GeneOntologyBiologicalProcess	G protein-coupled receptor signaling pathway	OR2B2 TRHR OR2T27 OR5AU1 OR2T35 OR4Q3 LGR4 TAAR2 OR2T1 DGKQ NLRP6 OR1F1 OR1L8 ADORA1 OR5J2 OR4S1 OR6B3 DGKK C3 C3AR1 OR6B2	1.75e-05	1395	112	21	GO:0007186
GeneOntologyBiologicalProcess	detection of stimulus	OR2B2 OR2T27 OR5AU1 OR2T35 OR4Q3 OR2T1 NOD2 OR1F1 OR1L8 ADORA1 OR5J2 OR4S1 OR6B3 OR6B2	3.69e-05	722	112	14	GO:0051606
GeneOntologyBiologicalProcess	sensory perception of chemical stimulus	OR2B2 OR2T27 OR5AU1 OR2T35 OR4Q3 OR2T1 OR1F1 OR1L8 OR5J2 OR4S1 OR6B3 OR6B2	4.26e-05	547	112	12	GO:0007606
GeneOntologyBiologicalProcess	xenophagy	RIPK2 NOD2 WIPI2	6.76e-05	15	112	3	GO:0098792
GeneOntologyBiologicalProcess	complement receptor mediated signaling pathway	CR2 C3 C3AR1	8.29e-05	16	112	3	GO:0002430
GeneOntologyBiologicalProcess	interleukin-18 production	NLRP6 NOD2 NLRP9	1.00e-04	17	112	3	GO:0032621
GeneOntologyBiologicalProcess	developmental process involved in reproduction	ZNF628 ADAM21 TOPAZ1 PRAMEF15 LGR4 NDP PRAMEF4 TESK1 ZFPM2 TGFB2 PSME4 RNASE10 ERRFI1 MARF1 PLA2G4A C3 GARIN1B PRAMEF11	1.15e-04	1235	112	18	GO:0003006
GeneOntologyBiologicalProcess	cone retinal bipolar cell differentiation	NDP BBS10	1.74e-04	4	112	2	GO:1904390
GeneOntologyBiologicalProcess	sensory perception	OR2B2 OR2T27 OR5AU1 OR2T35 OR4Q3 OR2T1 NDP TECTA BBS10 OR1F1 OR1L8 ADORA1 OR5J2 OR4S1 OR6B3 OR6B2	2.19e-04	1072	112	16	GO:0007600
GeneOntologyCellularComponent	Cul2-RING ubiquitin ligase complex	PRAMEF9 PRAMEF15 PRAMEF4 ASB4 PRAMEF27 PRAMEF11	2.06e-07	47	114	6	GO:0031462
GeneOntologyCellularComponent	cullin-RING ubiquitin ligase complex	PRAMEF9 PRAMEF15 KLHL41 PRAMEF4 ASB4 FBXL20 FBXL2 PRAMEF27 PRAMEF11	2.47e-06	212	114	9	GO:0031461
GeneOntologyCellularComponent	ubiquitin ligase complex	PRAMEF9 PRAMEF15 KLHL41 PRAMEF4 ASB4 FBXL20 FBXL2 PRAMEF27 PRAMEF11	1.35e-04	352	114	9	GO:0000151
Domain	-	NLRP11 PRAMEF25 PRAMEF15 SLITRK4 LGR4 PRAMEF4 SHOC2 NLRP6 NOD2 NLRP9 FBXL20 FBXL2 PRAMEF27 TBCEL	6.94e-09	321	111	14	3.80.10.10
Domain	L_dom-like	NLRP11 PRAMEF25 PRAMEF15 SLITRK4 LGR4 PRAMEF4 SHOC2 NLRP6 NOD2 NLRP9 FBXL20 FBXL2 PRAMEF27 TBCEL	9.13e-09	328	111	14	IPR032675
Domain	GPCR_Rhodpsn_7TM	OR2B2 TRHR OR2T27 OR5AU1 OR2T35 OR4Q3 LGR4 TAAR2 OR2T1 OR1F1 OR1L8 ADORA1 OR5J2 OR4S1 OR6B3 C3AR1 OR6B2	4.33e-07	670	111	17	IPR017452
Domain	7tm_1	OR2B2 TRHR OR2T27 OR5AU1 OR2T35 OR4Q3 LGR4 TAAR2 OR2T1 OR1F1 OR1L8 ADORA1 OR5J2 OR4S1 OR6B3 C3AR1 OR6B2	5.00e-07	677	111	17	PF00001
Domain	G_PROTEIN_RECEP_F1_1	OR2B2 TRHR OR2T27 OR5AU1 OR2T35 OR4Q3 LGR4 TAAR2 OR2T1 OR1F1 OR1L8 ADORA1 OR5J2 OR4S1 OR6B3 C3AR1 OR6B2	5.89e-07	685	111	17	PS00237
Domain	G_PROTEIN_RECEP_F1_2	OR2B2 TRHR OR2T27 OR5AU1 OR2T35 OR4Q3 LGR4 TAAR2 OR2T1 OR1F1 OR1L8 ADORA1 OR5J2 OR4S1 OR6B3 C3AR1 OR6B2	6.65e-07	691	111	17	PS50262
Domain	GPCR_Rhodpsn	OR2B2 TRHR OR2T27 OR5AU1 OR2T35 OR4Q3 LGR4 TAAR2 OR2T1 OR1F1 OR1L8 ADORA1 OR5J2 OR4S1 OR6B3 C3AR1 OR6B2	6.78e-07	692	111	17	IPR000276
Domain	Olfact_rcpt	OR2B2 OR2T27 OR5AU1 OR2T35 OR4Q3 OR2T1 OR1F1 OR1L8 OR5J2 OR4S1 OR6B3 OR6B2	3.85e-06	393	111	12	IPR000725
Domain	PRAME_family	PRAMEF25 PRAMEF15 PRAMEF4 PRAMEF27	4.28e-06	19	111	4	IPR026271
Domain	NACHT	NLRP11 NLRP6 NOD2 NLRP9	9.59e-06	23	111	4	PS50837
Domain	NACHT_NTPase	NLRP11 NLRP6 NOD2 NLRP9	9.59e-06	23	111	4	IPR007111
Domain	LRR_6	NLRP11 NOD2 NLRP9 FBXL20 FBXL2	1.86e-05	55	111	5	PF13516
Domain	-	NLRP11 RIPK2 NLRP6 NOD2 NLRP9 CARD6	1.93e-05	93	111	6	1.10.533.10
Domain	DEATH-like_dom	NLRP11 RIPK2 NLRP6 NOD2 NLRP9 CARD6	2.75e-05	99	111	6	IPR011029
Domain	TIL	VWF TECTA MUC5AC	4.32e-05	12	111	3	PF01826
Domain	C8	VWF TECTA MUC5AC	4.32e-05	12	111	3	PF08742
Domain	Unchr_dom_Cys-rich	VWF TECTA MUC5AC	5.59e-05	13	111	3	IPR014853
Domain	C8	VWF TECTA MUC5AC	5.59e-05	13	111	3	SM00832
Domain	TIL_dom	VWF TECTA MUC5AC	7.09e-05	14	111	3	IPR002919
Domain	VWC	VWF TECTA THBS2 MUC5AC	7.46e-05	38	111	4	SM00214
Domain	VWFC_2	VWF TECTA THBS2 MUC5AC	7.46e-05	38	111	4	PS50184
Domain	CARD	RIPK2 NOD2 CARD6	1.08e-04	16	111	3	SM00114
Domain	VWD	VWF TECTA MUC5AC	1.08e-04	16	111	3	SM00216
Domain	VWF_type-D	VWF TECTA MUC5AC	1.08e-04	16	111	3	IPR001846
Domain	VWFD	VWF TECTA MUC5AC	1.08e-04	16	111	3	PS51233
Domain	VWD	VWF TECTA MUC5AC	1.08e-04	16	111	3	PF00094
Domain	VWF_dom	VWF TECTA THBS2 MUC5AC	1.11e-04	42	111	4	IPR001007
Domain	CTCK_1	VWF NDP MUC5AC	1.56e-04	18	111	3	PS01185
Domain	VWC_out	VWF TECTA MUC5AC	1.85e-04	19	111	3	SM00215
Domain	Leu-rich_rpt	NLRP11 SLITRK4 LGR4 SHOC2 NOD2 NLRP9 FBXL20 FBXL2	2.16e-04	271	111	8	IPR001611
Domain	DAPIN	NLRP11 NLRP6 NLRP9	2.90e-04	22	111	3	PS50824
Domain	PYRIN	NLRP11 NLRP6 NLRP9	2.90e-04	22	111	3	PF02758
Domain	DAPIN	NLRP11 NLRP6 NLRP9	2.90e-04	22	111	3	IPR004020
Domain	PYRIN	NLRP11 NLRP6 NLRP9	2.90e-04	22	111	3	SM01289
Domain	CT	VWF NDP MUC5AC	2.90e-04	22	111	3	SM00041
Domain	Cys_knot_C	VWF NDP MUC5AC	4.27e-04	25	111	3	IPR006207
Domain	CTCK_2	VWF NDP MUC5AC	4.27e-04	25	111	3	PS01225
Domain	CARD	RIPK2 NOD2 CARD6	6.01e-04	28	111	3	PF00619
Domain	VWC	VWF THBS2 MUC5AC	6.01e-04	28	111	3	PF00093
Domain	CARD	RIPK2 NOD2 CARD6	8.13e-04	31	111	3	IPR001315
Domain	RA	RIN3 DGKQ RADIL	8.13e-04	31	111	3	SM00314
Domain	CARD	RIPK2 NOD2 CARD6	9.79e-04	33	111	3	PS50209
Domain	VWFC_1	VWF THBS2 MUC5AC	1.26e-03	36	111	3	PS01208
Domain	RA	RIN3 DGKQ RADIL	1.37e-03	37	111	3	PS50200
Domain	DAGK_acc	DGKQ DGKK	1.53e-03	10	111	2	PF00609
Domain	Diacylglycerol_kin_accessory	DGKQ DGKK	1.53e-03	10	111	2	IPR000756
Domain	DAGKa	DGKQ DGKK	1.53e-03	10	111	2	SM00045
Domain	RA_dom	RIN3 DGKQ RADIL	1.72e-03	40	111	3	IPR000159
Domain	DAGKc	DGKQ DGKK	3.04e-03	14	111	2	SM00046
Domain	Diacylglycerol_kinase_cat_dom	DGKQ DGKK	3.49e-03	15	111	2	IPR001206
Domain	DAGK_cat	DGKQ DGKK	3.49e-03	15	111	2	PF00781
Domain	Glyco_hormone_CN	NDP MUC5AC	3.49e-03	15	111	2	IPR006208
Domain	DAGK	DGKQ DGKK	3.49e-03	15	111	2	PS50146
Domain	Cys_knot	NDP MUC5AC	3.49e-03	15	111	2	PF00007
Domain	EGF-like_dom	ADAM21 MUC13 TECTA HHIP THBS2 LTBP1	3.73e-03	249	111	6	IPR000742
Domain	NAD/diacylglycerol_kinase	DGKQ DGKK	4.49e-03	17	111	2	IPR016064
Domain	Leu-rich_rpt_Cys-con_subtyp	FBXL20 FBXL2	5.60e-03	19	111	2	IPR006553
Domain	LRR_CC	FBXL20 FBXL2	5.60e-03	19	111	2	SM00367
Pathway	REACTOME_OLFACTORY_SIGNALING_PATHWAY	OR2B2 OR2T27 OR5AU1 OR2T35 OR4Q3 OR2T1 OR1F1 OR1L8 OR5J2 OR4S1 OR6B3 OR6B2	1.60e-06	417	74	12	M4072
Pathway	KEGG_OLFACTORY_TRANSDUCTION	OR2B2 OR2T27 OR5AU1 OR4Q3 OR2T1 OR1F1 OR1L8 OR5J2 OR4S1 OR6B3 OR6B2	5.38e-06	389	74	11	M14091
Pathway	REACTOME_SENSORY_PERCEPTION	OR2B2 OR2T27 OR5AU1 OR2T35 PCLO OR4Q3 OR2T1 OR1F1 OR1L8 OR5J2 OR4S1 OR6B3 OR6B2	2.34e-05	636	74	13	M41834
Pathway	WP_COMPLEMENT_AND_COAGULATION_CASCADES	VWF CR2 C3 C3AR1	2.40e-04	58	74	4	M39649
Pathway	WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES	VWF CR2 C3 C3AR1	2.56e-04	59	74	4	M48343
Pubmed	Differences in gene expression between mouse and human for dynamically regulated genes in early embryo.	PRAMEF15 PRAMEF4 NLRP9 PRAMEF27 PRAMEF11	3.20e-08	28	114	5	25089626
Pubmed	Different evolutionary processes shaped the mouse and human olfactory receptor gene families.	OR2B2 OR5AU1 OR2T35 OR4Q3 OR2T1 OR1F1 OR1L8 OR5J2 OR6B3 OR6B2	1.93e-07	340	114	10	11875048
Pubmed	The olfactory receptor gene superfamily of the mouse.	OR2B2 OR5AU1 OR2T35 OR4Q3 OR2T1 OR1F1 OR1L8 OR5J2 OR6B3 OR6B2	1.93e-07	340	114	10	11802173
Pubmed	A unified nomenclature for vertebrate olfactory receptors.	OR2B2 OR5AU1 OR2T35 OR4Q3 OR2T1 OR1F1 OR1L8 OR5J2 OR6B3 OR6B2	2.10e-07	343	114	10	32295537
Pubmed	Odorant receptor expressed sequence tags demonstrate olfactory expression of over 400 genes, extensive alternate splicing and unequal expression levels.	OR2B2 OR5AU1 OR2T35 OR4Q3 OR2T1 OR1F1 OR1L8 OR5J2 OR6B3 OR6B2	2.27e-07	346	114	10	14611657
Pubmed	The human olfactory receptor gene family.	OR2B2 OR2T27 OR5AU1 OR2T35 OR4Q3 OR2T1 OR1F1 OR1L8 OR5J2 OR4S1 OR6B3 OR6B2	2.33e-07	541	114	12	14983052
Pubmed	Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins.	PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	5.09e-07	20	114	4	26694250
Pubmed	Sertoli cell-only phenotype and scRNA-seq define PRAMEF12 as a factor essential for spermatogenesis in mice.	PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	7.65e-07	22	114	4	31729367
Pubmed	Cutting Edge: Neutrophil Complement Receptor Signaling Is Required for BAFF-Dependent Humoral Responses in Mice.	CR2 C3 C3AR1	1.19e-06	7	114	3	36454023
Pubmed	MAGE-B4, a binding partner of PRAMEF12, is dispensable for spermatogenesis and male fertility in mice.	PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	1.31e-06	25	114	4	37451217
Pubmed	Retinoic acid receptors are required for skeletal growth, matrix homeostasis and growth plate function in postnatal mouse.	PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	5.30e-06	35	114	4	19389355
Pubmed	Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis.	RIN3 TGFB2 HHIP	5.55e-06	11	114	3	24621683
Pubmed	Genome-wide association identifies regulatory Loci associated with distinct local histogram emphysema patterns.	RIN3 TGFB2 HHIP	7.38e-06	12	114	3	25006744
Pubmed	RIP2 filament formation is required for NOD2 dependent NF-κB signalling.	RIPK2 NOD2	1.07e-05	2	114	2	30279485
Pubmed	Microglia aggravate white matter injury via C3/C3aR pathway after experimental subarachnoid hemorrhage.	C3 C3AR1	1.07e-05	2	114	2	38866102
Pubmed	Multi-functional norrin is a ligand for the LGR4 receptor.	LGR4 NDP	1.07e-05	2	114	2	23444378
Pubmed	Solution structure of the complex formed between human complement C3d and full-length complement receptor type 2.	CR2 C3	1.07e-05	2	114	2	18804116
Pubmed	Cigarette smoke extract (CSE) delays NOD2 expression and affects NOD2/RIPK2 interactions in intestinal epithelial cells.	RIPK2 NOD2	1.07e-05	2	114	2	21931826
Pubmed	RIP2 promotes FcγR-mediated reactive oxygen species production.	RIPK2 NOD2	1.07e-05	2	114	2	31113864
Pubmed	Solution structure of the complex between CR2 SCR 1-2 and C3d of human complement: an X-ray scattering and sedimentation modelling study.	CR2 C3	1.07e-05	2	114	2	15713468
Pubmed	Mutational analysis of the complement receptor type 2 (CR2/CD21)-C3d interaction reveals a putative charged SCR1 binding site for C3d.	CR2 C3	1.07e-05	2	114	2	15713467
Pubmed	Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein.	CR2 C3	1.07e-05	2	114	2	11728339
Pubmed	Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses.	RIPK2 NOD2	1.07e-05	2	114	2	21123652
Pubmed	Dissociable effects of complement C3 and C3aR on survival and morphology of adult born hippocampal neurons, pattern separation, and cognitive flexibility in male mice.	C3 C3AR1	1.07e-05	2	114	2	34403734
Pubmed	C3a-C3aR signaling promotes breast cancer lung metastasis via modulating carcinoma associated fibroblasts.	C3 C3AR1	1.07e-05	2	114	2	31931851
Pubmed	Optimal germinal center B cell activation and T-dependent antibody responses require expression of the mouse complement receptor Cr1.	CR2 C3	1.07e-05	2	114	2	23733878
Pubmed	A crystal structure of the complex between human complement receptor 2 and its ligand C3d.	CR2 C3	1.07e-05	2	114	2	21527715
Pubmed	Endothelial progenitor cell transplantation alleviated ischemic brain injury via inhibiting C3/C3aR pathway in mice.	C3 C3AR1	1.07e-05	2	114	2	31865842
Pubmed	Delineation of the complement receptor type 2-C3d complex by site-directed mutagenesis and molecular docking.	CR2 C3	1.07e-05	2	114	2	20951140
Pubmed	Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation.	C3 C3AR1	1.07e-05	2	114	2	18812470
Pubmed	Complement activation is required for induction of a protective antibody response against West Nile virus infection.	CR2 C3	1.07e-05	2	114	2	15919902
Pubmed	Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis.	C3 C3AR1	1.07e-05	2	114	2	28283064
Pubmed	A dual role for receptor-interacting protein kinase 2 (RIP2) kinase activity in nucleotide-binding oligomerization domain 2 (NOD2)-dependent autophagy.	RIPK2 NOD2	1.07e-05	2	114	2	22665475
Pubmed	Joint NOD2/RIPK2 signaling regulates IL-17 axis and contributes to the development of experimental arthritis.	RIPK2 NOD2	1.07e-05	2	114	2	22491249
Pubmed	Defective engraftment of C3aR-/- hematopoietic stem progenitor cells shows a novel role of the C3a-C3aR axis in bone marrow homing.	C3 C3AR1	1.07e-05	2	114	2	19357704
Pubmed	Postbiotics for NOD2 require nonhematopoietic RIPK2 to improve blood glucose and metabolic inflammation in mice.	RIPK2 NOD2	1.07e-05	2	114	2	32101030
Pubmed	Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression.	C3 C3AR1	1.07e-05	2	114	2	29118090
Pubmed	Cutting edge: members of the Staphylococcus aureus extracellular fibrinogen-binding protein family inhibit the interaction of C3d with complement receptor 2.	CR2 C3	1.07e-05	2	114	2	19017934
Pubmed	C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury.	C3 C3AR1	1.07e-05	2	114	2	15240660
Pubmed	Spontaneous complement activation on human B cells results in localized membrane depolarization and the clustering of complement receptor type 2 and C3 fragments.	CR2 C3	1.07e-05	2	114	2	19740327
Pubmed	Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models.	C3 C3AR1	1.07e-05	2	114	2	11342658
Pubmed	Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection.	CR2 C3	1.07e-05	2	114	2	11927943
Pubmed	Downregulation of complement C3 and C3aR expression in subcutaneous adipose tissue in obese women.	C3 C3AR1	1.07e-05	2	114	2	24743347
Pubmed	Receptor for complement peptide C3a: a therapeutic target for neonatal hypoxic-ischemic brain injury.	C3 C3AR1	1.07e-05	2	114	2	23737250
Pubmed	Negative regulation of pulmonary Th17 responses by C3a anaphylatoxin during allergic inflammation in mice.	C3 C3AR1	1.07e-05	2	114	2	23285141
Pubmed	Interaction of iC3b with recombinant isotypic and chimeric forms of CR2.	CR2 C3	1.07e-05	2	114	2	1830068
Pubmed	CARD tricks: controlling the interactions of CARD6 with RICK and microtubules.	RIPK2 CARD6	1.07e-05	2	114	2	16582588
Pubmed	NOD2 Suppresses Colorectal Tumorigenesis via Downregulation of the TLR Pathways.	RIPK2 NOD2	1.07e-05	2	114	2	28658623
Pubmed	A minimum CR2 binding domain of C3d enhances immunity following vaccination.	CR2 C3	1.07e-05	2	114	2	16893077
Pubmed	Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils.	RIPK2 NOD2	1.07e-05	2	114	2	24766550
Pubmed	Complement component 3 is required for optimal expansion of CD8 T cells during a systemic viral infection.	CR2 C3	1.07e-05	2	114	2	12517942
Pubmed	Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis.	C3 C3AR1	1.07e-05	2	114	2	15383607
Pubmed	Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses.	CR2 C3	1.07e-05	2	114	2	9794381
Pubmed	The solvent at antigen-binding site regulated C3d-CR2 interactions through the C-terminal tail of C3d at different ion strengths: insights from molecular dynamics simulation.	CR2 C3	1.07e-05	2	114	2	27154286
Pubmed	Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow.	C3 C3AR1	1.07e-05	2	114	2	14604969
Pubmed	Complement component 3C3 and C3a receptor are required in chitin-dependent allergic sensitization to Aspergillus fumigatus but dispensable in chitin-induced innate allergic inflammation.	C3 C3AR1	1.07e-05	2	114	2	23549917
Pubmed	A short isoform of NOD2/CARD15, NOD2-S, is an endogenous inhibitor of NOD2/receptor-interacting protein kinase 2-induced signaling pathways.	RIPK2 NOD2	1.07e-05	2	114	2	16492792
Pubmed	Generation of recombinant human C3dg tetramers for the analysis of CD21 binding and function.	CR2 C3	1.07e-05	2	114	2	11684127
Pubmed	Complement pathway amplifies caspase-11-dependent cell death and endotoxin-induced sepsis severity.	C3 C3AR1	1.07e-05	2	114	2	27697835
Pubmed	The mouse anaphylatoxin C3a receptor: molecular cloning, genomic organization, and functional expression.	C3 C3AR1	1.07e-05	2	114	2	9164946
Pubmed	Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression.	CR2 C3	1.07e-05	2	114	2	15128761
Pubmed	Inhibiting the complement system does not reduce injury in renal ischemia reperfusion.	CR2 C3	1.07e-05	2	114	2	11423567
Pubmed	NOD2-RIP2-Mediated Signaling Helps Shape Adaptive Immunity in Visceral Leishmaniasis.	RIPK2 NOD2	1.07e-05	2	114	2	27651416
Pubmed	Solvation effects in calculated electrostatic association free energies for the C3d-CR2 complex and comparison with experimental data.	CR2 C3	1.07e-05	2	114	2	20091675
Pubmed	The complement C3-C3aR pathway mediates microglia-astrocyte interaction following status epilepticus.	C3 C3AR1	1.07e-05	2	114	2	33314324
Pubmed	Structure of complement receptor 2 in complex with its C3d ligand.	CR2 C3	1.07e-05	2	114	2	11387479
Pubmed	The electrostatic nature of C3d-complement receptor 2 association.	CR2 C3	1.07e-05	2	114	2	15187133
Pubmed	Mapping of the C3d ligand binding site on complement receptor 2 (CR2/CD21) using nuclear magnetic resonance and chemical shift analysis.	CR2 C3	1.07e-05	2	114	2	19164292
Pubmed	The NOD2-RICK complex signals from the plasma membrane.	RIPK2 NOD2	1.07e-05	2	114	2	17355968
Pubmed	Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB.	RIPK2 NOD2	1.07e-05	2	114	2	11087742
Pubmed	The Complement C3a-C3a Receptor Axis Regulates Epithelial-to-Mesenchymal Transition by Activating the ERK Pathway in Pancreatic Ductal Adenocarcinoma.	C3 C3AR1	1.07e-05	2	114	2	35220210
Pubmed	The genetics of NOD-like receptors in Crohn's disease.	NLRP11 NLRP6 NLRP9	1.22e-05	14	114	3	20403135
Pubmed	NALPs: a novel protein family involved in inflammation.	NLRP11 NLRP6 NLRP9	1.22e-05	14	114	3	12563287
Pubmed	Dynamic regulation of B cell complement signaling is integral to germinal center responses.	CR2 C3 C3AR1	1.86e-05	16	114	3	34031614
Pubmed	Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse.	PRAMEF15 PRAMEF4 PRAMEF11	2.26e-05	17	114	3	23565261
Pubmed	Mouse Pramel1 regulates spermatogonial development by inhibiting retinoic acid signaling during spermatogenesis.	PRAMEF15 PRAMEF4 PRAMEF11	2.26e-05	17	114	3	37781892
Pubmed	The promoter of the oocyte-specific gene, Oog1, functions in both male and female meiotic germ cells in transgenic mice.	PRAMEF15 PRAMEF4 PRAMEF11	2.70e-05	18	114	3	23894331
Pubmed	Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos.	PRAMEF15 PRAMEF4 PRAMEF11	2.70e-05	18	114	3	12890732
Pubmed	Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes.	PRAMEF15 PRAMEF4 PRAMEF11	2.70e-05	18	114	3	29731491
Pubmed	Identification of a new expanding family of genes characterized by atypical LRR domains. Localization of a cluster preferentially expressed in oocyte.	PRAMEF15 PRAMEF4 PRAMEF11	2.70e-05	18	114	3	14675769
Pubmed	Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation.	PRAMEF15 PRAMEF4 PRAMEF11	2.70e-05	18	114	3	39181896
Pubmed	Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis.	C3 C3AR1	3.19e-05	3	114	2	20625009
Pubmed	Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis.	C3 C3AR1	3.19e-05	3	114	2	32717081
Pubmed	Nod1 and Nod2 regulation of inflammation in the Salmonella colitis model.	RIPK2 NOD2	3.19e-05	3	114	2	20921147
Pubmed	The clearance mechanism of chilled blood platelets.	VWF C3	3.19e-05	3	114	2	12526796
Pubmed	Hepatic NOD2 promotes hepatocarcinogenesis via a RIP2-mediated proinflammatory response and a novel nuclear autophagy-mediated DNA damage mechanism.	RIPK2 NOD2	3.19e-05	3	114	2	33413510
Pubmed	A critical role for complement C3d and the B cell coreceptor (CD19/CD21) complex in the initiation of inflammatory arthritis.	CR2 C3	3.19e-05	3	114	2	16210644
Pubmed	A calcium-dependent phospholipase A2 (cPLA2) expression is regulated by MIG-6 during endometrial tumorigenesis.	ERRFI1 PLA2G4A	3.19e-05	3	114	2	30773264
Pubmed	Caspase recruitment domain protein 6 is a microtubule-interacting protein that positively modulates NF-kappaB activation.	RIPK2 CARD6	3.19e-05	3	114	2	16418290
Pubmed	A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1.	TGFB2 LTBP1	3.19e-05	3	114	2	2022183
Pubmed	Complement component C3a plays a critical role in endothelial activation and leukocyte recruitment into the brain.	C3 C3AR1	3.19e-05	3	114	2	26822321
Pubmed	CD19 can regulate B lymphocyte signal transduction independent of complement activation.	CR2 C3	3.19e-05	3	114	2	11544305
Pubmed	Association between peripheral blood WBCs C3aR mRNA level and plasma C3a, C3aR, IL-1β concentrations and acute exacerbation of chronic obstructive pulmonary disease.	C3 C3AR1	3.19e-05	3	114	2	34923262
Pubmed	Nod2 is required for the regulation of commensal microbiota in the intestine.	RIPK2 NOD2	3.19e-05	3	114	2	19805227
Pubmed	Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).	CR2 C3	3.19e-05	3	114	2	10477568
Pubmed	Impaired antibody response to group B streptococcal type III capsular polysaccharide in C3- and complement receptor 2-deficient mice.	CR2 C3	3.19e-05	3	114	2	12496386
Pubmed	Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cells.	C3 C3AR1	3.19e-05	3	114	2	15284858
Pubmed	Polymorphisms of CHAT but not TFAM or VR22 are Associated with Alzheimer Disease Risk.	CHAT CTNNA3	3.19e-05	3	114	2	27272392
Pubmed	The kinase activity of Rip2 determines its stability and consequently Nod1- and Nod2-mediated immune responses.	RIPK2 NOD2	3.19e-05	3	114	2	19473975
Pubmed	Genome-scale CRISPR screening reveals that C3aR signaling is critical for rapid capture of fungi by macrophages.	C3 C3AR1	3.19e-05	3	114	2	36174103
Cytoband	1p36.21	PRAMEF25 PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF11	5.41e-07	63	114	5	1p36.21
Cytoband	Ensembl 112 genes in cytogenetic band chr1p36	PRAMEF25 PRAMEF9 PRAMEF15 PRAMEF4 ERRFI1 ZBTB40 DISP3 PRAMEF27 PRAMEF11	5.36e-05	681	114	9	chr1p36
Cytoband	8q23	TRHR ZFPM2	9.11e-04	18	114	2	8q23
Cytoband	1q44	OR2T27 OR2T35 OR2T1	2.65e-03	110	114	3	1q44
GeneFamily	PRAME family	PRAMEF25 PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11	1.50e-09	24	89	6	686
GeneFamily	NLR family	NLRP11 NLRP6 NOD2 NLRP9	6.41e-06	25	89	4	666
GeneFamily	Pyrin domain containing\|Pyrin and HIN domain family	NLRP11 NLRP6 NLRP9	2.45e-04	25	89	3	994
GeneFamily	WD repeat domain containing\|Caspase recruitment domain containing\|Apoptosome	RIPK2 NOD2 CARD6	4.25e-04	30	89	3	959
GeneFamily	Complement system\|Sushi domain containing	CR2 C3 C3AR1	7.32e-04	36	89	3	492
GeneFamily	EF-hand domain containing\|Diacylglycerol kinases	DGKQ DGKK	1.05e-03	10	89	2	1178
GeneFamily	Olfactory receptors, family 2	OR2B2 OR2T27 OR2T35 OR2T1	2.35e-03	113	89	4	149
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF777 ZNF628 KLF14 ZNF205 ZBTB42 ZNF879 ZFPM2 ZNF276 ZBTB40 ZNF574	2.75e-03	718	89	10	28
GeneFamily	Ring finger proteins\|Fanconi anemia complementation groups\|Protein phosphatase 1 regulatory subunits\|BRCA1 A complex\|BRCA1 B complex\|BRCA1 C complex	XRCC2 PALB2	4.30e-03	20	89	2	548
GeneFamily	F-box and leucine rich repeat proteins	FBXL20 FBXL2	4.73e-03	21	89	2	558
GeneFamily	CD molecules\|Mucins	MUC13 MUC5AC	4.73e-03	21	89	2	648
ToppCell	E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HEATR1 SHISAL1 NOD2 SAMD9L C3 LONRF3	4.66e-06	169	113	6	305cedbd97059029d7d2a248a8a4b6cfe281aa54
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TRIB2 RNF183 MUC13 SAMD9L C3 MUC5AC	1.06e-05	195	113	6	3f8ed20ad17afe1545e574e5ca5fe33c3704c7f3
ToppCell	ASK452-Epithelial-Transformed_epithelium\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	COBLL1 SLC26A9 TGFB2 HHIP ERRFI1 C3	1.12e-05	197	113	6	b22a79a5922c865a360e2afc5506a08a512fa76a
ToppCell	ASK452-Epithelial-Transformed_epithelium\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	GAPDH COBLL1 SLC26A9 TGFB2 HHIP C3	1.12e-05	197	113	6	e92757e988888347c74286cc42c262b03159b0b9
Disease	vital capacity	RIN3 ZNF628 TRHR PCLO LGR4 INO80 OR1F1 TGFB2 HHIP THBS2 ERRFI1 CTNNA3 ZBTB40 LTBP1 FBXL20 FBXL2	6.72e-06	1236	104	16	EFO_0004312
Disease	asthma (biomarker_via_orthology)	CHAT PLA2G4A C3AR1 MUC5AC	5.71e-05	59	104	4	DOID:2841 (biomarker_via_orthology)
Disease	Hypospadias	HHIP DGKK	1.22e-04	5	104	2	C0848558
Disease	Carotid Circulation Transient Ischemic Attack	ADORA1 C3	5.44e-04	10	104	2	C0751019
Disease	Transient Ischemic Attack	ADORA1 C3	5.44e-04	10	104	2	C0007787
Disease	Crescendo Transient Ischemic Attacks	ADORA1 C3	5.44e-04	10	104	2	C0751021
Disease	Transient Ischemic Attack, Vertebrobasilar Circulation	ADORA1 C3	5.44e-04	10	104	2	C0751020
Disease	Brain Stem Ischemia, Transient	ADORA1 C3	5.44e-04	10	104	2	C0751022
Disease	Posterior Circulation Transient Ischemic Attack	ADORA1 C3	5.44e-04	10	104	2	C0472381
Disease	Transient Ischemic Attack, Anterior Circulation	ADORA1 C3	5.44e-04	10	104	2	C1527335
Disease	Transient Cerebral Ischemia	ADORA1 C3	5.44e-04	10	104	2	C0917805
Disease	rhinitis (is_marker_for)	C3 C3AR1 MUC5AC	5.78e-04	46	104	3	DOID:4483 (is_marker_for)
Disease	smoking behavior, BMI-adjusted waist circumference	COBLL1 TGFB2 HHIP LTBP1	9.30e-04	122	104	4	EFO_0004318, EFO_0007789
Disease	rhinitis (biomarker_via_orthology)	C3 MUC5AC	9.36e-04	13	104	2	DOID:4483 (biomarker_via_orthology)
Disease	pre-eclampsia (implicated_via_orthology)	C3 ASB4	9.36e-04	13	104	2	DOID:10591 (implicated_via_orthology)
Disease	BMI-adjusted waist circumference, physical activity measurement	COBLL1 TGFB2 HHIP LTBP1	9.59e-04	123	104	4	EFO_0007789, EFO_0008002
Disease	asthma (is_marker_for)	ADORA1 C3 C3AR1 MUC5AC	1.05e-03	126	104	4	DOID:2841 (is_marker_for)
Disease	red blood cell density measurement	TRIB2 GLS2 CDIN1 COBLL1 INO80 ZFPM2 POLI ZBTB40 FBXL20 WIPI2	1.10e-03	880	104	10	EFO_0007978
Disease	BMI-adjusted leptin measurement	COBLL1 KLF14	1.25e-03	15	104	2	EFO_0007793
Disease	systemic lupus erythematosus (is_implicated_in)	CR2 NOD2 C3	1.38e-03	62	104	3	DOID:9074 (is_implicated_in)
Disease	Dermatitis	NOD2 PLA2G4A	1.43e-03	16	104	2	C0011603
Disease	leptin measurement, type 2 diabetes mellitus	COBLL1 KLF14	1.43e-03	16	104	2	EFO_0005000, MONDO_0005148
Disease	body fat percentage, type 2 diabetes mellitus	COBLL1 KLF14	1.62e-03	17	104	2	EFO_0007800, MONDO_0005148
Disease	diabetic neuropathy (biomarker_via_orthology)	TGFB2 HHIP	1.62e-03	17	104	2	DOID:9743 (biomarker_via_orthology)
Disease	leprosy, Crohn's disease	RIPK2 NOD2	2.24e-03	20	104	2	EFO_0000384, EFO_0001054
Disease	lean body mass	ZNF777 ZNF628 TRHR HHIP ZBTB40 LTBP1	2.28e-03	379	104	6	EFO_0004995
Disease	asthma (is_implicated_in)	NOD2 ADORA1 C3 C3AR1	2.35e-03	157	104	4	DOID:2841 (is_implicated_in)
Disease	triglyceride measurement, body fat percentage	COBLL1 KLF14	2.47e-03	21	104	2	EFO_0004530, EFO_0007800
Disease	bone density, lean body mass	RIN3 ZBTB40	2.47e-03	21	104	2	EFO_0003923, EFO_0004995
Disease	venous thromboembolism, plasminogen activator inhibitor 1 measurement	VWF ZFPM2	2.47e-03	21	104	2	EFO_0004286, EFO_0004792
Disease	amino acid measurement	VWF GLS2 COBLL1 SHOC2 OR4S1 ZBTB40 PLA2G4A LTBP1	2.78e-03	678	104	8	EFO_0005134
Disease	venous thromboembolism, tissue plasminogen activator measurement	VWF ZFPM2	2.97e-03	23	104	2	EFO_0004286, EFO_0004791
Disease	high density lipoprotein particle size measurement	VPS11 COBLL1 KLF14 DGKQ	3.13e-03	170	104	4	EFO_0008592
Disease	Fanconi Anemia	XRCC2 PALB2	3.50e-03	25	104	2	C0015625
Disease	body fat percentage, high density lipoprotein cholesterol measurement	COBLL1 KLF14	3.50e-03	25	104	2	EFO_0004612, EFO_0007800
Disease	liver fibrosis measurement	VWF ZFPM2 NLRP6	3.52e-03	86	104	3	EFO_0010576

Protein segments in the cluster

Peptide	Gene	Start	Entry
ISCITCSGLFQEKPH	DISP3	781	Q9P2K9
HILNCITLFCPSCHK	ADORA1	251	P30542
SLSVLSHVCLPETCN	ADAM21	626	Q9UKJ8
FCTTPSSILCAKQLV	ASB4	146	Q9Y574
LTLLSSHCQLCPAAR	CCNJL	46	Q8IV13
LLHNPAFCSLATTKR	C3	866	P01024
VTLTKPTFCHLCSDF	DGKQ	66	P52824
CPAHESLTHICLKSF	ASB6	256	Q9NWX5
LISTCAFIPHSIVLC	BBS10	386	Q8TAM1
CCLSLPFSLAHLALQ	C3AR1	71	Q16581
HASLQELAPIICSKC	COBLL1	166	Q53SF7
ASLACNTHFCPIAEK	ADAMTS16	1171	Q8TE57
LNCSALPCLLHLLSS	KPNA5	336	O15131
NLCSCPLLKSLVFSS	INO80	961	Q9ULG1
PAFLLCLCIQHSATH	RADIL	436	Q96JH8
LFACPKTDSLAHCIS	OARD1	21	Q9Y530
DKPQSICCLHTMLSL	RAB3GAP2	786	Q9H2M9
CPKLQALSLSHCELI	FBXL2	311	Q9UKC9
SACSCPLLIFINSKS	DGKK	486	Q5KSL6
FFPLLKVCCLTINSH	OR2T1	11	O43869
PTCQISHLSLMKCDL	NLRP11	716	P59045
GSLNVKCLATPCHTS	HAGH	146	Q16775
AHQISSLCPFPQCTK	ZFPM2	291	Q8WW38
PRKCSVFHLFVACLS	B4GALT7	26	Q9UBV7
APSCRNHIKSSCSLI	CORO7	31	P57737
LAFPASVHDSLICSK	FAM135A	56	Q9P2D6
KTICPLCNTTELLLH	PCLO	586	Q9Y6V0
HPLSVHLTKQLCCCS	LTBP1	691	Q14766
CASHLTVVSLIFVPC	OR4Q3	241	Q8NH05
FCDVHPLLKLACADT	OR4S1	176	Q8NGB4
CVLLESDLKHLSQCP	PRAMEF15	306	P0DUQ1
DKSLPCHRLILSACS	KLHL41	41	O60662
IKSHSCPALAVASCQ	LGR4	876	Q9BXB1
HSVGHTKIPFCLQSC	GLS2	206	Q9UI32
ICQLILSKVFEPCHT	MUC5AC	5146	P98088
HFFCEVPALLKLSCT	OR2T27	176	Q8NH04
HFFCEIPAVLKLSCT	OR2T35	176	Q8NGX2
HFFCDIPSLLKLSCS	OR5J2	176	Q8NH18
TCAVCKFPHLVPASL	OLIG1	246	Q8TAK6
LVTHCLVPKNCSSPS	GARIN1B	211	Q96KD3
HFFCDVTPLLKLSCS	OR1F1	176	O43749
CTPQLAHLKDSVCLA	PALB2	756	Q86YC2
SISLLKSLHAEFLPC	GLYATL3	256	Q5SZD4
LKENSPLLHSICSAC	CTNNA3	211	Q9UI47
LKCLFSTFPQSAAIC	CARD6	76	Q9BX69
PLCKLSLLAVQCSHV	CR2	591	P20023
KACFPTNIVTLCHSI	CDIN1	266	Q9Y2V0
TNATAVRCCKLPLHA	C3orf80	56	F5H4A9
IQLSSVPKVSCCAHC	MARF1	91	Q9Y4F3
SCPLCPKQFSRSDHL	KLF14	256	Q8TD94
LVSCCSSLKETHFPF	HEATR1	711	Q9H583
FHLTLLSVCFCNLKA	POLI	426	Q9UNA4
PLCHLSSLTLSHCKL	NLRP6	726	P59044
SSLTLSHCKLPDAVC	NLRP6	731	P59044
HFFCDISPILKLACT	OR6B2	176	Q6IFH4
HFFCEVPALLKLSCV	OR2B2	176	Q9GZK3
SSSKQLVLCVHFPSL	RIN3	91	Q8TB24
STPKCSCGQLAAVHL	RNF180	101	Q86T96
TAQCPLPLFTCLHVK	PLA2G4A	321	P47712
HHFLCDLSPVLKLSC	OR1L8	176	Q8NGR8
CFCKTHPSDLGLSVN	SLITRK4	346	Q8IW52
SPEHKFLCALCVSAL	SMYD4	436	Q8IYR2
LCCALFPQKSSIHIS	SFXN3	281	Q9BWM7
FCVECLAHLSLVTPA	RNF183	36	Q96D59
AICHPIKAQFLCTFS	TRHR	126	P34981
FFKIHVICCALSVTL	SLC26A9	381	Q7LBE3
LFCHLDPCLLQSKES	SAMD9L	1306	Q8IVG5
NSLIHTGCIFSLKFC	OR5AU1	206	Q8NGC0
SIHCPRLQVLSLSHC	FBXL20	321	Q96IG2
SCTTNCLAPLAKVIH	GAPDH	151	P04406
CVLLESDLKHLSQCP	PRAMEF25	306	A6NGN4
HSLPFELALCSKLSI	SHOC2	531	Q9UQ13
HCPRLSDNKTFILCC	SHISAL1	46	Q3SXP7
CLPHLVLSCVKVASL	SH3TC1	721	Q8TE82
CVLLESDLKHLSQCP	PRAMEF27	306	A3QJZ7
PFCGHKNICSLATIQ	WIPI2	326	Q9Y4P8
TQSLLSLLVHCCSAP	INTS5	776	Q6P9B9
HFFCDISPILKLACT	OR6B3	176	Q8NGW1
SFNKPAIRISNCCIH	ERRFI1	256	Q9UJM3
KCALCSPHSQSLFHS	HHIP	111	Q96QV1
KCLQSLCDLRLSPHF	RRP12	511	Q5JTH9
PETILFCISSFHSCK	CHAT	686	P28329
VASLCAALKHPGCSI	NLRP9	816	Q7RTR0
GFVLSTSQCVPLHKC	TECTA	636	O75443
KISLHCPCCTFVPSN	TGFB2	221	P61812
CVLLESDLKHLSQCP	PRAMEF4	306	O60810
KCSICNSALELPSVH	VPS11	821	Q9H270
SSHCQVLLLPLFAEC	VWF	2136	P04275
SLCVKLHNTSFCLCL	MUC13	186	Q9H3R2
HLKLTFCSVGPTECA	NOD2	766	Q9HC29
CHKSSRPFDLTLCEL	RNASE10	166	Q5GAN6
TPNLSHCVSCIGKYL	TRIB2	51	Q92519
FCDHKTTPCSSAIIN	RIPK2	406	O43353
CVLLESDLKHLSQCP	PRAMEF9	306	P0DUQ2
LHSCPCGKTFVNLTK	ZNF574	391	Q6ZN55
SLKVVHELPACTLCA	TRIM15	6	Q9C019
RQDPTLSPFVCKSCH	ZNF276	126	Q8N554
CVLLESDLKHLSQCP	PRAMEF11	306	O60813
LGKIFSSCFHNTILC	TAAR2	331	Q9P1P5
FLLLAIHCCNLEPST	TESK1	286	Q15569
HSCKLLCGPVSTSVF	TBCC	231	Q15814
ESLKLFVPHCCSVIT	PSME4	641	Q14997
HQPCMKLLTFRCSSA	PLEKHH1	266	Q9ULM0
FSTVLKQPFRSSCHC	NDP	81	Q00604
MFCSHPSLCLLILDS	XRCC2	136	O43543
CPLCSKLFPSSHVLQ	ZBTB42	296	B2RXF5
NSVLKLRDCNCFPHS	TOPAZ1	221	Q8N9V7
CPACRKSFSHHSTLI	ZNF205	366	O95201
CNICGKIFLHSSSLS	ZNF879	206	B4DU55
FKTICHQITCPPATC	THBS2	346	P35442
CSLCGKSFSRPSHLL	ZNF777	696	Q9ULD5
VSCPSICCHSLKLLH	TBCEL	166	Q5QJ74
IEICHLLCSVHKSFP	ZBTB40	641	Q9NUA8
CPLCPKTFTHSSNLL	ZNF628	206	Q5EBL2
CPLCPKTFTHSSNLL	ZNF628	596	Q5EBL2
SDPVSLSCGHTFCKL	LONRF3	166	Q496Y0